Persistence of vaccinia at the site of smallpox vaccination.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 18171221.
- Also identified by DOI 10.1086/524078.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Persistence of vaccinia at vaccination sites may help determine the risk associated with secondary transmission. Culture, PCR, and antigen detection were performed on serial vaccination site swab specimens. On day 21 after vaccination, 37% of volunteers were culture positive, most of whom had received vaccine for the first time. Vaccinia is detectable at least through day 21 after vaccination.
Medical subject headings
- Smallpox
- Smallpox Vaccine
- Vaccinia virus